Adavosertib and Gemcitabine in Advanced Pancreatic
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study is being done to test the safety and effectiveness of combining Adavosertib and
Gemcitabine in patients with pancreatic cancer.
The names of the study drugs involved in this study are:
- Adavosertib
- Gemcitabine
Phase:
Phase 2
Details
Lead Sponsor:
James Cleary, MD, PhD
Collaborators:
AstraZeneca Lustgarten Foundation Stand Up To Cancer